1. Home
  2. GEHC vs MKL Comparison

GEHC vs MKL Comparison

Compare GEHC & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • MKL
  • Stock Information
  • Founded
  • GEHC 1892
  • MKL 1930
  • Country
  • GEHC United States
  • MKL United States
  • Employees
  • GEHC N/A
  • MKL N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • MKL Property-Casualty Insurers
  • Sector
  • GEHC Technology
  • MKL Finance
  • Exchange
  • GEHC Nasdaq
  • MKL Nasdaq
  • Market Cap
  • GEHC 28.1B
  • MKL 24.0B
  • IPO Year
  • GEHC N/A
  • MKL 1986
  • Fundamental
  • Price
  • GEHC $62.37
  • MKL $1,768.53
  • Analyst Decision
  • GEHC Buy
  • MKL Hold
  • Analyst Count
  • GEHC 11
  • MKL 5
  • Target Price
  • GEHC $97.73
  • MKL $1,702.20
  • AVG Volume (30 Days)
  • GEHC 5.9M
  • MKL 62.2K
  • Earning Date
  • GEHC 04-30-2025
  • MKL 04-30-2025
  • Dividend Yield
  • GEHC 0.22%
  • MKL N/A
  • EPS Growth
  • GEHC 43.17
  • MKL 35.61
  • EPS
  • GEHC 4.34
  • MKL 199.32
  • Revenue
  • GEHC $19,672,000,000.00
  • MKL $16,620,762,999.00
  • Revenue This Year
  • GEHC $3.79
  • MKL N/A
  • Revenue Next Year
  • GEHC $4.73
  • MKL $4.64
  • P/E Ratio
  • GEHC $14.37
  • MKL $8.87
  • Revenue Growth
  • GEHC 0.61
  • MKL 5.17
  • 52 Week Low
  • GEHC $57.65
  • MKL $1,417.65
  • 52 Week High
  • GEHC $94.80
  • MKL $2,063.68
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 31.41
  • MKL 44.23
  • Support Level
  • GEHC $60.70
  • MKL $1,751.57
  • Resistance Level
  • GEHC $64.80
  • MKL $1,800.00
  • Average True Range (ATR)
  • GEHC 3.61
  • MKL 61.45
  • MACD
  • GEHC -0.45
  • MKL -0.98
  • Stochastic Oscillator
  • GEHC 20.21
  • MKL 56.28

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About MKL Markel Group Inc.

Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little less than 15% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.

Share on Social Networks: